News Focus
News Focus
icon url

Doc logic

12/03/19 10:43 PM

#254269 RE: maverick_1 #254230

maverick_1,

Anything to do with gut biome as with Merck's program likely has irritable bowel syndrome as one of the undisclosed targets as it can be treated with fecal matter transplant now but this newer treatment seems like it would fit right in as a much more refined and acceptable application of the science. Best wishes.
icon url

Dr Bala

12/03/19 11:14 PM

#254273 RE: maverick_1 #254230

Excellent post, Mav.
icon url

maverick_1

12/11/19 1:00 AM

#255146 RE: maverick_1 #254230

Dr.Carlo Rago (@rago_carlo)
12/9/19, 3:54 PM
$NWBO #GBM
Full article showing [mOS of 35.9 months here:
ncbi.nlm.nih.gov/pmc/articles/P…
=========================
Dr. Carlo Rago (@rago_carlo)
12/9/19, 3:31 PM
$NWBO expectations
"If we include only those who received the DC vaccine in the newly diagnosed setting (n=15), the median overall survival is 35.9 months, with a mean follow-up time of over four years, and one, two and three-year survival rates of 93%, 77% and 58%,respectively."
pic.twitter.com/ZPWGUOJpVY

RE: Lot’s of recurring (non stop?) bamboozling grandstanding NONSENSE today lead by RECALCITRANTS
serve no constructive purpose!